Brandon Sim - Apollo Medical President
3AM Stock | EUR 33.00 0.40 1.20% |
President
Brandon Sim is Chief Operating Officer, Chief Technology Officer, Vice President of Engineering of Apollo Medical Holdings since 2021.
Age | 25 |
Tenure | 3 years |
Brandon Sim Latest Insider Activity
Tracking and analyzing the buying and selling activities of Brandon Sim against Apollo Medical stock is an integral part of due diligence when investing in Apollo Medical. Brandon Sim insider activity provides valuable insight into whether Apollo Medical is net buyers or sellers over its current business cycle. Note, Apollo Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Apollo Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Brandon Sim over two months ago Disposition of 2626 shares by Brandon Sim of Astrana Health at 57.87 subject to Rule 16b-3 | ||
Brandon Sim over six months ago Acquisition by Brandon Sim of 86305 shares of Astrana Health subject to Rule 16b-3 |
Apollo Medical Holdings Leadership Team
Elected by the shareholders, the Apollo Medical's board of directors comprises two types of representatives: Apollo Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Apollo. The board's role is to monitor Apollo Medical's management team and ensure that shareholders' interests are well served. Apollo Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Apollo Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Li Yu, Independent Director | ||
John Chiang, Independent Director | ||
Ernest Bates, Independent Director | ||
Kenneth Sim, Chairman of the Board, Co-Chief Executive Officer, Executive Director | ||
Mitchell Kitayama, Lead Independent Director | ||
Linda Marsh, Director | ||
Thomas Lam, President, Co-Chief Executive Officer, Director | ||
Albert Young, Chief Administrative Officer | ||
Mark Fawcett, Independent Director | ||
Brandon Sim, Chief Operating Officer, Chief Technology Officer, Vice President of Engineering | ||
David Schmidt, Independent Director | ||
Michael Eng, Independent Director | ||
Eric Chin, Chief Financial Officer, Interim Co-Chief Operating Officer, Secretary | ||
Adrian Vazquez, Co-Chief Medical Officer | ||
Matthew Mazdyasni, Director |
Apollo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Apollo Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Current Valuation | 1.28 B | |||
Price To Book | 2.60 X | |||
Price To Sales | 1.29 X | |||
Revenue | 1.14 B | |||
EBITDA | 112.08 M | |||
Net Income | 49.05 M | |||
Total Debt | 203.39 M | |||
Cash Flow From Operations | 70.33 M | |||
Number Of Employees | 15 | |||
Market Capitalization | 197.6 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Apollo Stock
Apollo Medical financial ratios help investors to determine whether Apollo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Apollo with respect to the benefits of owning Apollo Medical security.